Russia's Pharmstandard to buy little-known Singaporean business for $630 million

[temasek]

650 миллионов - не слабо для малоизвестной сингапурской фирмы...которая вроде есть, а в интернете нет...


...

Russia's Pharmstandard to buy little-known Singaporean business for $630 million
http://rbth.asia/business/2013/07/10/russias_pharmstandard_to_buy_little-known_singaporean_business_for_6_47835.html
July 10, 2013 Kommersant

Russia's largest pharmaceutical company Pharmstandard is reportedly planning to spend $630 million to buy Singapore-based Bever Pharmaceutical Pte Ltd, which has up to now been pretty much under the radar of the Russian market.

The money for the deal, which is termed as a related party transaction, may come from Pharmstandard's planned sale of its spin-off over-the-counter operation. In its bid to sell the unit, the company is believed to be offering dissenting shareholders a 20-per-cent discount to the market value of their stock.

Pharmstandard is "in advanced discussions" with regard to the Bever deal, the company announced to the London Stock Exchange on 8 July.

In its information disclosure statement, Pharmstandard elaborates that it intends to purchase 100 per cent (50,000 shares) of Singapore-listed Bever Pharmaceutical Pte Ltd.

The transaction is expected to be cleared by Pharmstandard's extraordinary shareholder meeting, which is scheduled for 17 August.

None of the experts and market players polled by Kommersant appeared to be aware of Bever's existence.

Bever Pharmaceutical is not mentioned on the website of the Singapore Association of Pharmaceutical Industries.

Internet trawling produces no website for the company; however, it is understood that the domain name beverpharmaceutical.sg has already been taken.

Russian news agency Prime has reported the Pharmstandard press service as saying that Bever Pharmaceutical "develops and produces pharmaceutical ingredients essential for the manufacture of medications".

Ilya Krylov, head of the Pharmstandard corporate communications division, failed to disclose more about Bever Pharmaceutical to Kommersant by press time.
The fact that the potential deal has been submitted to the Pharmstandard shareholders as a related party transaction indicates that one of the Russian company's shareholders (holding 20 per cent or more of voting stock, including stock held by affiliated parties), or a member of the managing board or their relative, has affiliation with the Singaporean business.

[gorn]

650 миллионов - не слабо для малоизвестной сингапурской фирмы...которая вроде есть, а в интернете нет...

Компания торгуется на бирже, а в интернете о ней информации нет?! Чудеса.. Сенсация от Коммерсанта.. 

[дядя Сережа]

gorn, а попробуй найти хотя бы годовой график стоимости акций это немало известной (ведь ты так считаешь?) фирмы?

[gorn]

gorn, а попробуй найти хотя бы годовой график стоимости акций это немало известной (ведь ты так считаешь?) фирмы?

Я, дядя Сережа, ничего по поводу известности компании не считаю. Я знаю одно - plc - это public listed company. А значит вся информация об этой компании, которая не составляет коммерческой тайны, находится в публичном доступе. Нравится тебе это или нет, но таковы правила листинга на бирже.  А дальше уже если кто-то что-то не может найти - это его личные трудности.

[дядя Сережа]

gorn, малоизвестность и публичность - не взаимоисключающие понятия.